Cargando…

Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients

BACKGROUND: The United States is becoming increasingly diverse, but few molecular studies have assessed the progression of clear cell renal cell carcinoma (ccRCC) in diverse patient populations. This study examined ccRCC molecular variations in non‐Hispanic White (NHW) and Hispanic patients and thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Batai, Ken, Chen, Yuliang, Rheinheimer, Brenna A., Arora, Amit, Pandey, Ritu, Heimark, Ronald L., Bracamonte, Erika R., Ellis, Nathan A., Lee, Benjamin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278477/
https://www.ncbi.nlm.nih.gov/pubmed/37081700
http://dx.doi.org/10.1002/cam4.5929
_version_ 1785060494475788288
author Batai, Ken
Chen, Yuliang
Rheinheimer, Brenna A.
Arora, Amit
Pandey, Ritu
Heimark, Ronald L.
Bracamonte, Erika R.
Ellis, Nathan A.
Lee, Benjamin R.
author_facet Batai, Ken
Chen, Yuliang
Rheinheimer, Brenna A.
Arora, Amit
Pandey, Ritu
Heimark, Ronald L.
Bracamonte, Erika R.
Ellis, Nathan A.
Lee, Benjamin R.
author_sort Batai, Ken
collection PubMed
description BACKGROUND: The United States is becoming increasingly diverse, but few molecular studies have assessed the progression of clear cell renal cell carcinoma (ccRCC) in diverse patient populations. This study examined ccRCC molecular variations in non‐Hispanic White (NHW) and Hispanic patients and their effect on the association of gene expression with high‐grade (Grade 3 or 4) ccRCC and overall mortality. METHODS: A total of 156 patients were included in VHL sequencing and/or TempO‐Seq analysis. DESeq2 was used to identify the genes associated with high‐grade ccRCC. Logistic regression analysis was performed to assess whether race and ethnicity was associated with high/moderate impact VHL somatic mutations and the ccA/ccB subtype. Cox regression analysis was performed to assess association of molecular subtype and gene expression with overall mortality. RESULTS: NHWs had moderate or high impact mutations in the VHL gene at a higher frequency than Hispanics (40.2% vs. 27.4%), while Hispanics had a higher frequency of the ccA subtype than NHWs (61.9% vs. 45.8%). ccA was more common in patients with BMI≥35 (65.2%) than in those with BMI < 25 (45.0%). There were 11 differentially expressed genes between high‐ and low‐grade tumors. The Haptoglobin (HP) gene was most significantly overexpressed in high‐ compared to low‐grade ccRCC in all samples (p‐adj = 1.7 × 10(−12)). When stratified by subtype, the 11 genes were significantly differentially expressed in the ccB subtype, but none of them were significant after adjusting for multiple testing in ccA. Finally, patients with the ccB subtype had a significantly increased risk of overall mortality (HR 4.87; p = 0.01) compared to patients with ccA, and patients with high HP expression and ccB, had a significantly increased risk of mortality compared to those with low HP expression and ccA (HR 6.45, p = 0.04). CONCLUSION: This study reports ccRCC molecular variations in Hispanic patients who were previously underrepresented.
format Online
Article
Text
id pubmed-10278477
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102784772023-06-20 Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients Batai, Ken Chen, Yuliang Rheinheimer, Brenna A. Arora, Amit Pandey, Ritu Heimark, Ronald L. Bracamonte, Erika R. Ellis, Nathan A. Lee, Benjamin R. Cancer Med RESEARCH ARTICLES BACKGROUND: The United States is becoming increasingly diverse, but few molecular studies have assessed the progression of clear cell renal cell carcinoma (ccRCC) in diverse patient populations. This study examined ccRCC molecular variations in non‐Hispanic White (NHW) and Hispanic patients and their effect on the association of gene expression with high‐grade (Grade 3 or 4) ccRCC and overall mortality. METHODS: A total of 156 patients were included in VHL sequencing and/or TempO‐Seq analysis. DESeq2 was used to identify the genes associated with high‐grade ccRCC. Logistic regression analysis was performed to assess whether race and ethnicity was associated with high/moderate impact VHL somatic mutations and the ccA/ccB subtype. Cox regression analysis was performed to assess association of molecular subtype and gene expression with overall mortality. RESULTS: NHWs had moderate or high impact mutations in the VHL gene at a higher frequency than Hispanics (40.2% vs. 27.4%), while Hispanics had a higher frequency of the ccA subtype than NHWs (61.9% vs. 45.8%). ccA was more common in patients with BMI≥35 (65.2%) than in those with BMI < 25 (45.0%). There were 11 differentially expressed genes between high‐ and low‐grade tumors. The Haptoglobin (HP) gene was most significantly overexpressed in high‐ compared to low‐grade ccRCC in all samples (p‐adj = 1.7 × 10(−12)). When stratified by subtype, the 11 genes were significantly differentially expressed in the ccB subtype, but none of them were significant after adjusting for multiple testing in ccA. Finally, patients with the ccB subtype had a significantly increased risk of overall mortality (HR 4.87; p = 0.01) compared to patients with ccA, and patients with high HP expression and ccB, had a significantly increased risk of mortality compared to those with low HP expression and ccA (HR 6.45, p = 0.04). CONCLUSION: This study reports ccRCC molecular variations in Hispanic patients who were previously underrepresented. John Wiley and Sons Inc. 2023-04-20 /pmc/articles/PMC10278477/ /pubmed/37081700 http://dx.doi.org/10.1002/cam4.5929 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Batai, Ken
Chen, Yuliang
Rheinheimer, Brenna A.
Arora, Amit
Pandey, Ritu
Heimark, Ronald L.
Bracamonte, Erika R.
Ellis, Nathan A.
Lee, Benjamin R.
Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
title Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
title_full Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
title_fullStr Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
title_full_unstemmed Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
title_short Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
title_sort clear cell renal cell carcinoma molecular variations in non‐hispanic white and hispanic patients
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278477/
https://www.ncbi.nlm.nih.gov/pubmed/37081700
http://dx.doi.org/10.1002/cam4.5929
work_keys_str_mv AT bataiken clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT chenyuliang clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT rheinheimerbrennaa clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT aroraamit clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT pandeyritu clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT heimarkronaldl clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT bracamonteerikar clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT ellisnathana clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients
AT leebenjaminr clearcellrenalcellcarcinomamolecularvariationsinnonhispanicwhiteandhispanicpatients